MacKie R M, Aitchison T, Sirel J M, McLaren K, Watt D C
Department of Dermatology, University of Glasgow, UK.
Br J Cancer. 1995 Jan;71(1):173-6. doi: 10.1038/bjc.1995.35.
For the past 20 years thickness of the primary tumour has been accepted as the most important guide to prognosis for patients with primary cutaneous malignant melanoma. The changing epidemiology of melanoma with an increasing number of patients with thin tumours has necessitated a reappraisal of this, with particular reference to interactions among tumour thickness, the patients' sex and the presence or absence of ulceration of the primary tumour. All primary cutaneous malignant melanomas diagnosed in Scotland between 1979 and 1986 were used as the test group (1978 patients). The proportional hazards model was used on all potential risk factors in the database and their two-way interactions, and the resulting models based on stepwise procedures were subsequently validated on 289 melanoma patients first diagnosed in 1987 in the same geographic area. Four distinct subgroups of males and females with ulcerated or non-ulcerated lesions were identified. For females with ulcerated lesions, tumour thickness, mitotic count and anatomical site of primary all gave valuable prognostic information, whereas for females with non-ulcerated lesions only tumour thickness was of prognostic value. For males with ulcerated lesions, level of invasion was the only prognostic guide, while for males with non-ulcerated lesions both tumour thickness and level of invasion contributed significantly to prediction of prognosis. Prognosis markedly different across subgroups of the melanoma population, even to the extent that essential prognostic factors are not the same in the distinct subgroups. Verification of these prognostic guides derived from 1979-86 patients has been achieved for all patients diagnosed with melanoma in 1987 from the same geographic area. These data will therefore be useful aids for clinicians managing patients.
在过去20年里,原发性肿瘤的厚度一直被认为是原发性皮肤恶性黑色素瘤患者预后的最重要指标。随着黑色素瘤流行病学的变化,薄肿瘤患者数量不断增加,因此有必要对此进行重新评估,特别是考虑肿瘤厚度、患者性别以及原发性肿瘤有无溃疡之间的相互作用。1979年至1986年在苏格兰诊断出的所有原发性皮肤恶性黑色素瘤患者作为测试组(1978例患者)。对数据库中的所有潜在风险因素及其双向相互作用使用比例风险模型,随后在1987年首次在同一地理区域诊断出的289例黑色素瘤患者中对基于逐步程序得出的模型进行验证。确定了有溃疡或无溃疡病变的男性和女性的四个不同亚组。对于有溃疡病变的女性,肿瘤厚度、有丝分裂计数和原发性肿瘤的解剖部位均提供了有价值的预后信息,而对于无溃疡病变的女性,只有肿瘤厚度具有预后价值。对于有溃疡病变的男性,浸润深度是唯一的预后指标,而对于无溃疡病变的男性,肿瘤厚度和浸润深度均对预后预测有显著贡献。黑色素瘤患者亚组之间的预后明显不同,甚至在不同亚组中基本的预后因素也不相同。对于1987年在同一地理区域诊断出的所有黑色素瘤患者,已验证了从1979 - 86年患者得出的这些预后指标。因此,这些数据将有助于临床医生管理患者。